Add BrightSurf on Google Email

Palliative telecare significantly improves quality of life for those with chronic illnesses, and results last for months

Researchers found that a team intervention provided by phone leads to persistent improvements in depression, anxiety, and quality of life for people managing chronic illnesses. The program demonstrated early, persistent, and clinically meaningful improvements in adults with COPD, HF, or ILD.

SourceUniversity of Colorado Anschutz Medical Campus·JournalJournal of the American Medical Association·DateJan 16, 2024

The medical community should not stand silent on medicalized rape at CIA secret prisons, BU researchers argue in new commentary

Boston University School of Public Health researchers Sondra Crosby and Leonard Glantz denounce rectal feeding practices at CIA secret prisons, equating them to torture. They call for medical officers who authorized or participated in these nonconsensual practices to be held accountable for violating ethical and legal standards.

SourceBoston University School of Public Health·JournalJAMA·TypeCommentary/editorial·DateJan 16, 2024

Study finds paxlovid treatment does not reduce risk of long COVID

Researchers from UC San Francisco have found that Paxlovid treatment does not reduce the risk of developing long COVID. They also discovered a higher proportion of individuals with acute symptoms rebounding after treatment, and those who took Paxlovid were just as likely to develop severe Long COVID symptoms as those who did not.

SourceUniversity of California San Francisco Medical Center·JournalJournal of Medical Virology·TypeObservational study·DateJan 4, 2024

Sudden hearing loss: high-dose therapy does not lead to better outcomes than the standard treatment

A large-scale German-wide randomized controlled trial found that high-dose therapy with glucocorticoids is not more effective than standard treatment for sudden hearing loss. However, it was associated with a higher risk of side effects. Several hundred thousand people worldwide suffer from sudden hearing loss each year.

SourceMartin-Luther-Universität Halle-Wittenberg·JournalNEJM Evidence·TypeRandomized controlled/clinical trial·DateJan 4, 2024

Benzodiazepine use during pregnancy and risk of miscarriage

A nationwide case-time-control study found an association between benzodiazepine use during pregnancy and an increased risk of miscarriage. The results suggest that healthcare professionals should carefully weigh the benefits and risks of using benzodiazepines to treat psychiatric and sleep disorders in pregnant women.

SourceJAMA Network·JournalJAMA Psychiatry·DateDec 27, 2023

Viking dentistry was surprisingly advanced

A study of Viking Age teeth from Varnhem in Sweden found that 49% of the population had one or more caries lesions, with children's milk teeth being entirely caries-free. The Vikings also underwent dental treatment, including filing front teeth and relieving pressure through holes drilled into molars.

SourceUniversity of Gothenburg·JournalPLOS ONE·DateDec 14, 2023

Vikings in Sweden suffered from tooth decay

A study published in PLOS ONE reveals that Vikings in Sweden had a high prevalence of tooth decay, with many exhibiting severe caries and other dental pathologies. The findings provide insights into the lives of these ancient Scandinavians and their attempts to treat dental issues.

SourcePLOS·JournalPLOS ONE·TypeObservational study·DateDec 13, 2023

Brain waves usually found in sleep can protect against epileptic activity

Researchers at University College London have discovered that slow waves typically present during sleep can also occur during wakefulness in people with epilepsy, potentially protecting against increased brain excitability. These 'wake' slow waves decrease the impact of epileptic spikes on brain activity and may protect against seizures.

SourceUniversity College London·JournalNature Communications·TypeExperimental study·DateNov 30, 2023

OCD therapy retrains the brain

A new study finds that exposure and response prevention (EX/RP) therapy for OCD improves cognitive control by strengthening connections between brain networks. This breakthrough sheds light on the mechanisms underlying EX/RP's effectiveness in treating OCD, paving the way for targeted therapies.

SourceElsevier·JournalBiological Psychiatry Cognitive Neuroscience and Neuroimaging·TypeImaging analysis·DateNov 29, 2023

Study: cannabis use disorder increasing among veterans with psychiatric disorders

Research published in The American Journal of Psychiatry finds that cannabis use disorder is disproportionately increasing among veterans with psychiatric disorders, particularly those with more severe mental health conditions. The study suggests that factors like increased legalization and potency may contribute to this trend.

SourceAmerican Psychiatric Association·JournalAmerican Journal of Psychiatry·TypeData/statistical analysis·DateNov 29, 2023

Infertility and risk of autism spectrum disorder in children

A study of 1.3 million Canadian children found a higher risk of autism spectrum disorder in those born to parents with infertility. The research suggests that certain obstetrical and neonatal factors may contribute to this increased risk, highlighting the need for further exploration of these factors in individuals with infertility.

SourceJAMA Network·JournalJAMA Network Open·DateNov 20, 2023

Consumption of antibiotics in the community back to pre-pandemic levels in the European Union and European Economic Area

Community antibiotic consumption in the EU increased by 18.8% between 2021 and 2022, reversing a significant decline seen during the pandemic. The resurgence of infections may have contributed to the rebound, but highlights the need for continued prudent use of antibiotics.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeData/statistical analysis·DateNov 17, 2023

First comprehensive guideline on using biomarkers for monitoring Crohn’s disease

The American Gastroenterological Association released a new guideline recommending the use of biomarkers to help manage Crohn’s disease. Biomarkers such as C-reactive protein and fecal calprotectin can measure levels of inflammation, helping doctors assess disease activity and guide treatment decisions.

SourceAmerican Gastroenterological Association·JournalGastroenterology·TypeSystematic review·DateNov 17, 2023

New ‘patch’ uses natural body motion to fix disc herniation

Researchers developed 'tension-activated repair patches' that release anti-inflammatory molecules, helping discs regain tension and reverse herniation. The patch uses natural biomechanical movement to activate its release, offering a potential early intervention for preventing worsening pain related to disc degeneration.

SourceUniversity of Pennsylvania School of Medicine·JournalScience Translational Medicine·TypeData/statistical analysis·DateNov 15, 2023

Virologic rebound observed in 20% of patients treated with nirmatrelvir-ritonavir

A study found that 20% of patients treated with nirmatrelvir-ritavir (N-R) experienced virologic rebound, a phenomenon where viral load increases after initial decline. In contrast, only 1 untreated patient was affected. The researchers suggest considering the risks and benefits of N-R treatment in patients at low risk for severe disease.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateNov 13, 2023

Decline in estimated glomerular filtration rate after dapagliflozin in heart failure with mildly reduced or preserved ejection fraction

Patients with heart failure treated with dapagliflozin experienced frequent initial estimated glomerular filtration rate declines, but without increased cardiovascular or kidney event risks. The study suggests that sodium-glucose cotransporter-2 inhibitors can be safely continued in patients experiencing eGFR decline.

SourceJAMA Network·JournalJAMA Cardiology·DateNov 12, 2023

CNIC scientists identify the crucial role of the protein neuregulin-1 in heart development

Researchers at CNIC reveal the essential role of neuregulin-1 in transforming the delicate primordial heart structure into a powerful pumping organ. The study sheds light on the pathways of human heart formation and suggests new strategies for heart health and regenerative medicine.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalCirculation Research·TypeExperimental study·DateNov 10, 2023

Molecule tested at University of São Paulo, in Brazil, proves able to mitigate heart failure

Researchers at the University of São Paulo have tested a synthetic molecule called AD-9308, which has shown potential in treating heart failure by activating the enzyme aldehyde dehydrogenase 2. The study found that the molecule improved mitochondrial filtration, eliminating cellular pollutants and boosting heart function by up to 40%.

Poor night’s sleep can trigger atrial fibrillation the next day

A new study by UC San Francisco found that poor sleep is significantly associated with a 15% greater risk of experiencing atrial fibrillation the next day. The researchers suggest strategies like going to bed at a reasonable time, avoiding alcohol and caffeine before bedtime, and exercising regularly to improve general sleep quality.

SourceUniversity of California - San Francisco·JournalJACC Clinical Electrophysiology·DateNov 3, 2023

Chinese Medical Journal published updates on hypertensive heart disease burden in older adults

The study analyzed global data from the past three decades, revealing an overall increase in hypertensive heart disease (HHD) prevalence but a decrease in mortality and disability-adjusted life years (DALYs). The burden of HHD is particularly concerning for healthcare systems due to higher prevalence with lower mortality rates.

SourceCactus Communications·JournalChinese Medical Journal·TypeData/statistical analysis·DateOct 31, 2023